Skin Disorders encompass non-melanoma cancer, eczema types of autoimmune issues, and other causes of inflammation.
Non-melanoma skin cancers are one of the most common cancers diagnosed, with easy diagnosis and treatment. Treatment includes tools to shave off the cancerous tissue, using a topical electrical current to stop bleeding and zapping the remaining cancer cells.
Eczema, also called dermatitis depicts a group of non-contagious, inflammatory, typically itchy skin conditions including atopic dermatitis and irritant or allergic contact dermatitis. Treatment is to remove irritation and reduce immune response with topical or oral corticosteroids.
This program is designed to quickly and easily educate about how and why cannabinoids can be helpful for alleviating the symptoms of various Autoimmune conditions.
Autoimmune conditions affect up to 10% of the population and include Rheumatoid Arthritis, Lupus, Type 1 Diabetes, Psoriasis, and Inflammatory Bowel Disease. This pathway program is designed to quickly teach you how and why cannabinoids can be helpful for alleviating the symptoms of various Autoimmune conditions.
This program includes:v
CB1 and CB2 receptors, cannabinoids, and anandamide have diverse mechanisms underlying non-melanoma skin cancer pathologies. All three compounds (WIN-55,212-2, JWH-133, and AEA) were tested successfully against skin cancer cells in vitro (cell cultures). 3 Terpenes: Limonene, β-caryophyllene and phytol showed potential efficacy in the lab. Preclinical research shows activating CB2 skin receptors are anti-inflammatory, lessens itching, and have anti-microbial benefits.